Press Releases ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Delayed Nasdaq Stockholm Other stock markets 06:17:54 15/05/2024 pm IST			5-day change	1st Jan Change
1.414 ^SEK	-1.94%		-4.46%	-32.99%

16/04	ExpreS2ion Announces Completion of GLP Safety Study for ES2B-C001 (HER2-VLP) Breast Cancer Vaccine Candidate	CI
21/02	ExpreS2ion Biotech JV Secures EUR10 Million Following Bavarian Nordic's Completion of COVID-19 Vaccine Trial	MT

Press Releases

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

ExpreS2ion to present in spring investor events	06:48pm	AQ
ExpreS2ion Biotech : Annual report 2023 including Auditor’s report	08/05	PU
ExpreS2ion annual report for 2023 published	08/05	AQ
Notice to attend the Annual General Meeting in ExpreS2ion Biotech Holding AB (publ)	03/05	AQ
ExpreS2ion announces a rights issue of units of approximately SEK 60 million	03/05	AQ
ExpreS2ion to receive approximately SEK 22.5 million dividend payment from AdaptVac ApS	23/04	AQ
ExpreS2ion changes dates for the annual general meeting and the publication of the annual report for 2023	16/04	AQ
ExpreS2ion announces completion of GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate	16/04	AQ
ExpreS2ion to present in investor and R&D events in March	15/04	AQ
ExpreS2ion to present in investor and R&D events in March	29/02	AQ
ExpreS2ion's Associated Company AdaptVac Receives Milestone Payment Following Completion of Bavarian Nordic's Clinical Phase III Study for the COVID-19 Vaccine	21/02	AQ
ExpreS2ion announces financial results for the fourth quarter and full-year 2023	08/02	AQ
ExpreS2ion to present in Redeye Fight Cancer event and the Bio Innovation Leaders Summit	22/01	AQ
ExpreS2ion to present new Nipah virus vaccine project in upcoming webcast	12/12	AQ
Pareto Securities publishes research report	04/12	AQ
ExpreS2ion announces new EU-funded Horizon Europe grant award for Nipah virus vaccine development	01/12	AQ
ExpreS2ion CEO interviewed, CFO provides update at life science investor conference, Analysguiden publishes research report	27/11	AQ
ExpreS2ion announces financial results for the third quarter 2023	16/11	AQ
ExpreS2ion Biotechnologies: Bulletin from the Extraordinary General Meeting of ExpreS2ion Biotech Holding AB held on 9 November 2023	09/11	AQ
Background and rationale for the proposed incentive program 2023/2026	25/23/25	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Press Releases ExpreS2ion Biotech Holding AB

Equities

EXPRS2

SE0008348262

Press Releases

Filters